faculty portrait if available
Jill Comeau
Associate Professor
Clinical Sciences
PHSV 104
318-342-1814
ULM logo

Jill M Comeau, PharmD
Associate Professor, Pharmacy

Education

PharmD

2008, Pharmacy
Massachusetts College of Pharmacy Boston

faculty feature photo

Biographical Sketch

I am a board certified oncology pharmacist and currently practice as gratis assistant professor at the LSU-Health School of Medicine.  My practice site is located at the Feist-Weiller Cancer Center in Shreveport which serves patients from Shreveport to Monroe, East Texas, and as far south as Lake Charles.  We treat an indigent patient population with cancer according to evidence-based medicine as well as taking into account their social and economic struggles.

The clinics I am involved in include: breast, brain and sarcoma clinic, lung and head and neck clinic, digestive clinic, and benign and malignant hematology clinic.  My role is multifaceted and involves collaboration with hematology/oncology physicians and nurses to provide optimal patient care.  One of my main activities includes developing supportive care plans for cancer patients including but not limited to preventing and treating nausea and vomiting, pain, constipation, infections, etc.  I also counsel patients on oral cancer therapy, supportive care medications as well as verify home medications and herbal products to account for adherence as well as interactions with current cancer treatment.  I provide medication-based information to physicians as well as perform pharmacy informatics duties.

My main research areas of interest include retrospective reviews and patient education.  It has focused on efficacy, toxicity, and drug interactions with cancer treatments in patients with hematologic malignancies.  I am also expanding into research involving pharmacy-based medication education.  I am also interested in academic research regarding the role of pharmacy students in oncology practice.

Licensure & Certification

Medication Therapy Management Certificate Training Program, APhA. (July 2016 - Present)
Board Certified Oncology Pharmacist, BCOP, Board of Pharmacy Specialist. (December 1 2011 - December 31 2025)
Advanced Cardiac Life Support, American Heart Association. (May 2009 - July 2019)
Basic Life Support, American Heart Association. (January 14 2009 - July 2019)
Pharmacist, Louisiana Board of Pharmacy. (August 11 2010 - December 31 2018)
Pharmacist, Massachusetts Board of Pharmacy. (March 11 2009 - December 31 2018)
Pharmacist, Pennsylvania Board of Pharmacy. (August 18 2008 - September 30 2018)
Pharmacy Teaching Certificate, Mercer College of Pharmacy and Health Sciences. (June 4 2010 - June 4 2016)
Pharmacist, Georgia Board of Pharmacy. (June 9 2009 - December 31 2012)

Research Interests

  • Hematology/Oncology Patient Outcomes
  • Medication Adherence
  • Patient Education
  • Pharmacy Students Role in Oncology Services

Recent Publications

(2017). Pharmacist's application to practice, Niraparib (Zujula) for maintenance therapy in patients with platinum-sensitive recurrent epithelial ovarian cancer, fallopian tube, or primary peritoneal malignancy. Drug Updates. HOPA.
(2017). Hematology Oncology Pharmacy Association (HOPA) entry-level competencies task force response statement to the 2016 American College of Clinical Pharmacy (ACCP) pharmacotherapy didactic curriculum toolkit. (pp. e30-31). Pharmacotherapy.
Comeau, J. M., Jean, G., Kelly, K. (2018). Elotuzumab in the Treatment of Relapsed or Refractory Multiple Myeloma. Bethesda, MD: AJHP.
Comeau, J. M., Wehr, T., Peyton-Thomas, B. (2016). Efficacy and Cost Analysis of a Plerixafor Protocol for Peripheral Blood Stem Cell Mobilization in Patients Diagnosed with Multiple Myeloma and non-Hodgkin's Lymphoma. Baltimore, MD: JHOP.
Comeau, J. M. (2015). The role of obinutuzumab in the treatment of chronic lymphocytic leukemia (pp. 933-42). Bethesda, MD: American Journal of Health-System Pharmacy.
Comeau, J. M. (2014). Impact of race and payer status on the outcome of chronic myeloid leukemia in the era of tyrosine kinase inhibitors. (pp. e17568). Alexandria, VA: Journal of Clinical Oncology/American Society of Clinical Oncology.
Comeau, J. (2008). . Excessive anticoagulation and bleeding events; a case presentation. Roxbury, MA: eThrombosis, North American Thrombosis Forum.
Comeau, J. (2011). Romiplostin for the treatment of amegakaryocytic thrombocytopenia secondary to remission-inducing immunomodulation in a patient with relapsing Acute Lymphoblastic Leukemia after allogeneic HSCT (pp. abstract 6609). Alexandria, VA: ASCO/Journal of Clinical Oncology/2011 Annual Meeting Abstracts.
Comeau, J. (2011). Rapid remission induction through cytokine modulation in a patient with early relapse of acute lymphoblastic leukemia at unusual site after alllogeneic stem cell transplantation. Alexandria, VA: Journal of Clinical Oncology.
Comeau, J. (2012). Pharmacologic Prevention and Treatment of Sickle Cell Pain Crisis in Adults (pp. 6-7). Baton Rouge, LA: Louisiana Medicaid Provider Update.
Comeau, J. (2012). Successful treatment of first and second recurrence of acute lymphoblastic leukemia after related allogeneic bone marrow transplant at unusual sites using single-dose vincristine followed by interferon-alpha 2b and GMCSF (pp. 1-3). London: Leukemia Lymphoma.
Comeau, J., Labruzzo Mohundro, B. A. (2012). Lung Cancer Pipeline. Plainsboro, NJ: The American Journal Of Managed Care Evidence-Based Oncology.
Comeau, J., Labruzzo Mohundro, B. A. (2013). From Bench to Bedside, Promising Colon Cancer Clinical Trials. Plainsboro, NJ: The American Journal Of Managed Care Evidence-Based Oncology.
Comeau, J. (2013). The BMT Data Book, The BMT/SCT Pharmacopoeia, 3rd edition (pp. 816-1028). Cambridge: Cambridge University Press.
Comeau, J. (2013). Ponatinib: a new tyrosine kinase inhibitor for the treamtnet of chronic myeloid leukemia and Philadelphia chromosome-postiive acute lymphoblastic leukemia (pp. 1540-1546). Cincinnati, OH: The Annals of Pharmacotherapy/SAGE Publications.

Research Grants

Comeau, J. M. (Principal), Perry, E. C. (Co-Principal), Storer, A. (Co-Principal), Lafitte, E. M. (Co-Principal), "Computer-based Clinical Simulation for Health and Pharmaceutical Sciences" (Awarded, Not Yet Funded), Sponsored By ULM, The University of Louisiana at Monroe, $7880. (June 1 2015 - Present).
Comeau, J., "HOPA Travel Grant" (Funded), Sponsored By HOPA, External to The University of Louisiana at Monroe, $500. (February 1 2013 - March 20 2013).

Awards & Honors

January 2012 Gratis Asistant Professor of Medicine in the Feist Weiller Cancer Center and the Bone Marrow transplant unit of the LSUHSC-Shreveport.

Courses Taught

PHAR 5088Disease Pathogen & Pharm Iv, 1 course(s)

PHRD 4079SELF CARE/PATIENT ASSESS I MOD, 3 course(s)

PHRD 5004ADVANCED COMMUNICATION, 7 course(s)

PHRD 5035HEMATOLOGY/ONCOLOGY MODULE, 6 course(s)

PHRD 5051AGING DRUG USE IN ELDERLY, 6 course(s)

PHRD 5061WOMEN'S HEALTH AND PHARMACIST, 4 course(s)

PHRD 5065CLINICAL PHARMACY CAREER DEV, 3 course(s)

PHRD 5067PROBLEMS WITH THERAPEUTICS, 1 course(s)